Virtuoso Therapeutics is a bi-specific platform based oncology focused drug discovery and development company. The company has licensed core patents that constitute the BINSpecificTM technology (Bi-Specific Irreversible Non-Covalent Antibodies) from UCSF.

 

For more information please e-mail info@virtuosotherapeutics.com